Welcome to Indonesian Journal of Rheumatology

Indonesian Journal of Rheumatology is a peer-reviewed open access journal on rheumatic diseases and connective tissue disorders. This is an official journal of Indonesian Rheumatology Associantion (IRA) and published twice a year since 2009.

Indonesian Journal of Rheumatology (IJR)

is a peer-reviewed open access journal on rheumatic diseases and connective tissue disorders. This is an official journal of Indonesian Rheumatology Associantion (IRA) and published twice a year since 2009. Our mission is to encourage the development of scientific and medical practice in rheumatic diseases and connective tissue disorders. This journal is self-focused on rheumatic disease and connective tissue disorders in the form of original article (extended and/or concise reports), review articles, editorial letters, leaders, lesson from memorable cases, book reviews, and matter arising. Both in clinical and laboratory including animal studies.

Policy

Review Process

All unpublished manuscripts are confidential documents. If we invite you to review an article please do not discuss it even with a colleague: if you would like to pass it on to someone else to review please email jurnalreumatologi@gmail.com first.

As a reviewer you will be advising the editors, who make the final decision (aided by an editorial committee for all research articles and most analysis articles). We will let you know our decision. Authors - and readers too, if the paper is accepted and published - will see your signed report, so please do not make any comments that you are not prepared to stand by publicly. Even if we do not accept an article we would like to pass on constructive comments that might help the author to improve it.

Before you accept or decline an invitation to review, consider the following questions:

  • Does the article match your area of expertise? Only accept if you feel you can provide a high quality review.
  • Do you have a potential conflict of interest? Disclose this to the editor when you respond.
  • Do you have time? Reviewing can be a lot of work - before you commit, make sure you can meet the deadline

Respond to the invitation as soon as you can - delay in your decision slows down the review process, whether you agree to review or not. If you decline the invitation, provide suggestions for alternative reviewers. Please do not hesitate to contact the receiving editorial office.

Please give detailed and constructive comments (with references, whenever possible) that will both help the editors to make a decision on the article and the authors to improve it.

For all articles

  • Is the article important?
  • Will it help our readers to make better decisions and, if so, how?
  • Will the article add enough to existing knowledge?
  • Does the article read well and make sense? Does it have a clear message?

For research articles

  • Originality does the work add enough to what is already in the published literature? If so, what does it add? Please cite relevant references to support your comments on originality.
  • Importance of the work to general readers does this work matter to clinicians, researchers, policymakers, educators, or patients? Will it help our readers to make better decisions and, if so, how? Is a general medical journal the right place for it?
  • Scientific reliability
    • Research question clearly defined and appropriately answered?
    • Overall design of study appropriate and adequate to answer the research question?
    • Participants adequately described, their conditions defined, inclusion and exclusion criteria described? How representative were they of patients whom this evidence might affect?
    • Methods adequately described? Main outcome measure clear? Is the study fully reported in line with the appropriate reporting statement ? Was the study ethical (this may go beyond simply whether the study was approved by an ethics committee) ?
    • Results answer the research question? Credible? Well presented?
    • Interpretation and conclusions warranted by and sufficiently derived from/focused on the data? Discussed in the light of previous evidence? Message clear?
    • References up to date and relevant? Any glaring omissions?
    • Abstract/summary/key messages/what this paper adds reflect accurately what the paper says?
    • Documents in the supplemental files. Do these properly match what is in the manuscript? Do they contain information that should be better reported in the manuscript, or raise questions about the work?

Not all of these points will be relevant for non-research articles. Please use your discretion about the above list when reporting on other types of article.

 



Author Guideline

General Information

Indonesian Journal of Rheumatology (IJR) is issued every 6 months (January and July).

  • We accept original articles, review articles, and case reports related with rheumatic diseases and connective tissue disorders.
  • Manuscript should be submitted through website (journalrheumatology.or.id) with microsoft word format (doc or docx)
  • If manuscript contain figures or images, please send the real-size image, with resolution exceeding 300dpi.
  • Manuscript template is available here

Originality

  • Manuscripts haven't been published in other journals and should not be submitted simultaneously to any other publication.
  • Selected manuscript authors should completed a statement about the originality of the manuscript(s).

Review Process

  • The Editor-in-Chief and an Associate Editor generally review the submitted manuscripts. Then the selected manuscripts are reviewed by usually two reviewers. Upon completion of the review, notification of acceptance or rejection will be sent to the corresponding author by e-mail or notification on the web. If a revised version is requested, it should be returned no later than 14 days after notification.
  • The theme and research design are consistent with the result.

Manuscript Format

  • All manuscript should be written in clear and appropriate language. English language is prefered. The text must be typed in 12-point font with 1,15-line spacing and 2.5-cm margins (left, right, up and down-margin) on A4 size paper.
  • Title of manuscriptshouldless than 200 characters, including spaces
  • Author list contain following first name, middle name, and last name), followed by name of the institutions at which the work was performed; name, address, telephone, fax number, and e-mail address of the corresponding author
  • Abstract structure up to 300 words, containing Background, Methods, Results and Conclusions. The objectives, observations and main results should be provided. Keywords :Three to ten keywords, reflecting the contents of the manuscript
  • Introduction: consist of relevant background, brief review of the medical literature concisely with purpose of study, and objective of study clearly stated at the last paragraph. No subtitle is allowed in this section.
  • Methods: presented in flexible format, could explain in paragraphs or structure in substitles. Including: study plan (cross-sectional, case-control, cohort, randomized trial, etc), timed and placed study took, materials collecting methods including :subjects inclusion and exclusion criteria, laboratorium assesment: reagent, equipments, etc. Example:... the reagent used was Quantikine Human IL-17 Immunoassay (R and D System Inc., Minneapolis, USA), radiological assesment drug, substance, placebo preparation: method of preparation or manufacturer, and statistical analysis methods: test and programe used for data analysis, example: ... using t-test within Statistical Packages for Social Sciences (SPSS) version 20.
  • Result: decription of study result should be arranged in sturctured manner. The result could be presented within the text, using figures, or tables. The text should not repated the content of figures or tables, except for main findings, important trends, statistical significance or key points.
  • Discussion: Analyze important finding of the study, including argument, comparison with previous study, and plausibel hypotheses. Do not repeated the result of study, define and analysis significant finding that concisely related with the aims of study.
  • Conclusion should refer to the objective of study.
  • Additionally: Tables use three horizontal lines only. Number tables used for reference are mentioned in the main text. The title is placed above the table, using sentence case. Below each table, provide a key to abbreviations and additional explanations if needed. Tables and legends should provide enough detail that the study data can be understood without reference to the main text.Laboratory measurements should be expressed in SI (Standard International) units. A single space is usually required between the numeral and the unit; no space is inserted for % and ℃.
  • References: Reference use Vancouver style. Number of references should be ordered according to order of appearance in the text. For Indonesian article resources, title should be translated in English without altering the meaning. Articles used should be published at last 10 years.
    • Printed Journal : Fransen M, Edmonds J. Reliability and validity of the EuroQol in patients with osteoarthritis of the knee. Rheumatology 1999;38:807-13.
    • Online Journal: World Health Organization. Global tuberculosis control 2010. [Online]. 2010 [cited 2010 Nov]; Available from: URL:http://whqlibdoc.who.int/publications/2010/9789241564069_eng.pdf.
    • Books
      • Authors without editor: Lodish H, Baltimore D, Berk A, Zipursky SL, Matsudaira P, Darnell J. Molecular cell biology. 3rd ed. New York: Scientific American; 1995. p. 2-10
      • Author with Editor: Bennet JE. Aspergillosis. In:Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL, et al, editors. Harrison's principles of internal medicine. 16thed. New York: McGraw-Hill; 2008. p. 1188-90
      • Published by organization: World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 3rd edition. Geneva: World Health Organization; 2003
      • Chapter in books: Isbagio H, Albar Z, Kasjmir YI. Systemic lupus erythematosus [Lupus eritematosus sistemik]. In: Sudoyo AW, Setiyohadi B, Alwi I, Kolopaking MS, Setiati S, editors. Textbook of internal medicine [Buku ajar ilmu penyakit dalam]. 4th ed. Jakarta: Information and Publications Center, Department of Internal Medicine, University of Indonesia School of Medicine [Pusat Informasi dan Penerbitan Ilmu Penyakit Dalam FKUI]; 2006. p. 1224-31.
      • Online Books: Patrias K. Citing medicine: the NLM style guide for authors, editors, and publishers [Internet]. 2nd ed. Wendling DL, technical editor. Bethesda (MD): National Library of Medicine (US); 2007[updated 2015 Oct 2; cited Year Month Day]. Available from: http://www.nlm.nih.gov/citingmedicine
      • Thesis: Juariah N. Profile and five-year survival analysis of sustemic lupus erythematosus patients in Cipto Mangunkusumo General Hospital in 1999-2007 [Profil dan kesintasan lima tahun pada pasien lupus eritematosus sistemik di RSCM tahun 1999-2007] [specialist thesis]. [Jakarta]: University of Indonesia School of Medicine; 2008.
      • Conference or Scientific meeting materials: Kalim H, Handono K. Problems of the rheumatic diseases in Indonesia and efforts to overcome them [Masalah penyakit reumatik di Indonesia serta upaya-upaya penanggulangannya]. In: Setiyohadi B, Kasjmir YI, Mahfudzoh S, editors. Proceedings of the 2000 Rheumatology Scientific Meeting [Naskah lengkap Pertemuan Ilmiah Reumatologi 2000]; Jakarta: Indonesian Rheumatology Association; 2000. p. 1-11.

     

    Specific Rules:

    • Original article
      • Manuscripts consist of title, Authors list and institution, followed by abstracts and keywords, introduction, methods, results, discussion, and references. Tables and figures could be placed within the text or at the end of the articles. 
      • Total lenght of manuscripts shouldn't exceed 14 pages or about 5000 words for original articles..
    • Review article
      • Manuscripts consist of title, Authors list and institution, followed by abstracts and keywords, introduction, body, conclusion, and references. Details of body manuscript format may be flexible according to the contents.
      • Total lenght of manuscripts shouldn't exceed 14 pages or about 5000 words for review articles.
    • Case report
      • Manuscript begin with title, Authors list and institution, followed by abstracts and keywords, introduction, cases, outcome, discussion, conclusion, and references.
      • Total lenght of manuscripts shouldn't exceed 8 pages or about 3000 words for or case report

Privacy Statement

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Author Self Archive Policy

This journal permits and encourages authors to post items submitted to the journal on personal websites or institutional repositories both prior to and after publication, while providing bibliographic details that credit, if applicable, its publication in this journal..

Article Processing Charge

The payment of this fee will enable you to view, download, and print this article.

Copyright

The payment of this fee will enable you to view, download, and print this article.

Copyright © 2024 Perhimpunan Reumatologi Indonesia